|Articles|May 20, 2020
Characterization and Formulation Screening of mAb and ADCs by High Throughput-DLS
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
GSK’s Arexvy Gains EU Approval for Adults Aged 18 Years and Older
2
HanchorBio–WuXi Biologics Partnership Targets Fusion Protein Development Challenges
3
Optimizing Kinetics Assays to Avoid Avidity Effects
4
Industry Outlook 2026: Biopharma Industry Confronts Skills Shortage with Strategic Automation (Part 2)
5